01 1Biocon
01 1LINAGLIPTIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-16
Pay. Date : 2021-04-28
DMF Number : 35771
Submission : 2021-06-01
Status : Active
Type : II
20
Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LINAGLIPTIN, with a corresponding US DMF Number 35771.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 16, 2021, and payment made on April 28, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
